Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Nazareno Paolocci is active.

Publication


Featured researches published by Nazareno Paolocci.


Diabetes | 2012

GSH or Palmitate Preserves Mitochondrial Energetic/Redox Balance, Preventing Mechanical Dysfunction in Metabolically Challenged Myocytes/Hearts From Type 2 Diabetic Mice

Carlo G. Tocchetti; Viviane Caceres; Brian A. Stanley; Chaoqin Xie; Sa Shi; Walter H. Watson; Brian O’Rourke; Regina C. Spadari-Bratfisch; Sonia Cortassa; Fadi G. Akar; Nazareno Paolocci; Miguel A. Aon

In type 2 diabetes, hyperglycemia and increased sympathetic drive may alter mitochondria energetic/redox properties, decreasing the organelle’s functionality. These perturbations may prompt or sustain basal low-cardiac performance and limited exercise capacity. Yet the precise steps involved in this mitochondrial failure remain elusive. Here, we have identified dysfunctional mitochondrial respiration with substrates of complex I, II, and IV and lowered thioredoxin-2/glutathione (GSH) pools as the main processes accounting for impaired state 4→3 energetic transition shown by mitochondria from hearts of type 2 diabetic db/db mice upon challenge with high glucose (HG) and the β-agonist isoproterenol (ISO). By mimicking clinically relevant conditions in type 2 diabetic patients, this regimen triggers a major overflow of reactive oxygen species (ROS) from mitochondria that directly perturbs cardiac electro-contraction coupling, ultimately leading to heart dysfunction. Exogenous GSH or, even more so, the fatty acid palmitate rescues basal and β-stimulated function in db/db myocyte/heart preparations exposed to HG/ISO. This occurs because both interventions provide the reducing equivalents necessary to counter mitochondrial ROS outburst and energetic failure. Thus, in the presence of poor glycemic control, the diabetic patient’s inability to cope with increased cardiac work demand largely stems from mitochondrial redox/energetic disarrangements that mutually influence each other, leading to myocyte or whole-heart mechanical dysfunction.


Journal of Immunology | 2014

H2S Increases Survival During Sepsis: Protective Effect of CHOP Inhibition

Marcella Ferlito; Qihong Wang; William B. Fulton; Paul M. Colombani; Luigi Marchionni; Karen Fox-Talbot; Nazareno Paolocci; Charles Steenbergen

Sepsis is a major cause of mortality, and dysregulation of the immune response plays a central role in this syndrome. H2S, a recently discovered gaso-transmitter, is endogenously generated by many cell types, regulating a number of physiologic processes and pathophysiologic conditions. We report that H2S increased survival after experimental sepsis induced by cecal ligation and puncture (CLP) in mice. Exogenous H2S decreased the systemic inflammatory response, reduced apoptosis in the spleen, and accelerated bacterial eradication. We found that C/EBP homologous protein 10 (CHOP), a mediator of the endoplasmic reticulum stress response, was elevated in several organs after CLP, and its expression was inhibited by H2S treatment. Using CHOP-knockout (KO) mice, we demonstrated for the first time, to our knowledge, that genetic deletion of Chop increased survival after LPS injection or CLP. CHOP-KO mice displayed diminished splenic caspase-3 activation and apoptosis, decreased cytokine production, and augmented bacterial clearance. Furthermore, septic CHOP-KO mice treated with H2S showed no additive survival benefit compared with septic CHOP-KO mice. Finally, we showed that H2S inhibited CHOP expression in macrophages by a mechanism involving Nrf2 activation. In conclusion, our findings show a protective effect of H2S treatment afforded, at least partially, by inhibition of CHOP expression. The data reveal a major negative role for the transcription factor CHOP in overall survival during sepsis and suggest a new target for clinical intervention, as well potential strategies for treatment.


Journal of the American Heart Association | 2014

CCR5 Inhibition Prevents Cardiac Dysfunction in the SIV/Macaque Model of HIV

Kathleen Kelly; Carlo G. Tocchetti; Alexey E. Lyashkov; Patrick M. Tarwater; Djahida Bedja; David R. Graham; Sarah E. Beck; Kelly A. Metcalf Pate; Suzanne E. Queen; Robert J. Adams; Nazareno Paolocci; Joseph L. Mankowski

Background Diastolic dysfunction is a highly prevalent cardiac abnormality in asymptomatic as well as ART‐treated human immunodeficiency virus (HIV) patients. Although the mechanisms underlying depressed cardiac function remain obscure, diastolic dysfunction in SIV‐infected rhesus macaques is highly correlated with myocardial viral load. As cardiomyocytes are not productively infected, damage may be an indirect process attributable to a combination of pro‐inflammatory mediators and viral proteins. Methods and Results Given the diverse roles of CCR5 in mediating recruitment of leukocytes to inflammatory sites and serving as a receptor for HIV entry into cells, we investigated the role of CCR5 in the SIV/macaque model of diastolic dysfunction. We found that in SIV‐infected macaques, CCR5 inhibition dramatically impacted myocardial viral load measured by qRT‐PCR and prevented diastolic dysfunction measured by echocardiography. Complementary in vitro experiments using fluorescence microscopy showed that CCR5 ligands impaired contractile function of isolated cardiomyocytes, thus identifying CCR5 signaling as a novel mediator of impaired cardiac mechanical function. Conclusions Together, these findings incriminate SIV/HIV gp120‐CCR5 as well as chemokine‐CCR5 interactions in HIV‐associated cardiac dysfunction. These findings also have important implications for the treatment of HIV‐infected individuals: in addition to antiviral properties and reduced chemokine‐mediated recruitment and activation of inflammatory cells, CCR5 inhibition may provide a cardioprotective benefit by preventing cardiomyocyte CCR5 signaling.


Journal of Applied Physiology | 2013

Endocardial endothelium is a key determinant of force-frequency relationship in rat ventricular myocardium

Xiaoxu Shen; Zhen Tan; Xin Zhong; Ye Tian; Xian Wang; Bo Yu; Genaro A. Ramirez-Correa; Anne M. Murphy; Kathleen L. Gabrielson; Nazareno Paolocci; Wei Dong Gao

We tested the hypothesis that removing endocardial endothelium (EE) negatively impacts the force-frequency relationship (FFR) of ventricular myocardium and dissected the signaling that underlies this phenomenon. EE of rat trabeculae was selectively damaged by brief (<1 s) exposure to 0.1% Triton X-100. Force, intracellular Ca(2+) transient (iCa(2+)), and activity of protein kinase A (PKA) and protein kinase C (PKC) were determined. In control muscles, force and iCa(2+) increased as the stimulation frequency increased in steps of 0.5 Hz up to 3.0 Hz. However, EE-denuded (EED) muscles exhibited a markedly blunted FFR. Neither isoproterenol (ISO; 0.1-5 nmol/l) nor endothelin-1 (ET-1; 10-100 nmol/l) alone restored the slope of FFR in EED muscles. Intriguingly, however, a positive FFR was restored in EED preparations by combining low concentrations of ISO (0.1 nmol/l) and ET-1 (20 nmol/l). In intact muscles, PKA and PKC activity increased proportionally with the increase in frequency. This effect was completely lost in EED muscles. Again, combining ISO and ET-1 fully restored the frequency-dependent rise in PKA and PKC activity in EED muscles. In conclusion, selective damage of EE leads to significantly blunted FFR. A combination of low concentrations of ISO and ET-1 successfully restores FFR in EED muscles. The interdependence of ISO and ET-1 in this process indicates cross-talk between the β1-PKA and ET-1-PKC pathways for a normal (positive) FFR. The results also imply that dysfunction of EE and/or EE-myocyte coupling may contribute to flat (or even negative) FFR in heart failure.


The International Journal of Biochemistry & Cell Biology | 2012

Depletion of Cellular Glutathione Modulates LIF-Induced JAK1-STAT3 Signaling in Cardiac Myocytes

Mazen Kurdi; Vidhya Sivakumaran; Roy J. Duhé; Miguel A. Aon; Nazareno Paolocci; George W. Booz

Previously we reported that the sesquiterpene lactone parthenolide induces oxidative stress in cardiac myocytes, which blocks Janus kinase (JAK) activation by the interleukin 6 (IL-6)-type cytokines. One implication suggested by this finding is that IL-6 signaling is dependent upon cellular anti-oxidant defenses or redox status. Therefore, the present study was undertaken to directly test the hypothesis that JAK1 signaling by the IL-6-type cytokines in cardiac myocytes is impaired by glutathione (GSH) depletion, since this tripeptide is one of the major anti-oxidant molecules and redox-buffers in cells. Cardiac myocytes were pretreated for 6h with l-buthionine-sulfoximine (BSO) to inhibit GSH synthesis. After 24h, cells were dosed with the IL-6-like cytokine, leukemia inhibitory factor (LIF). BSO treatment decreased GSH levels and dose-dependently attenuated activation of JAK1, Signal Transducer and Activator of Transcription 3 (STAT3), and extracellular signal regulated kinases 1 and 2 (ERK1/2). Addition of glutathione monoethyl ester, which is cleaved intracellularly to GSH, prevented attenuation of LIF-induced JAK1 and STAT3 activation, as did the reductant N-acetyl-cysteine. Unexpectedly, LIF-induced STAT1 activation was unaffected by GSH depletion. Evidence was found that STAT3 is more resistant than STAT1 to intermolecular disulfide bond formation under oxidizing conditions and more likely to retain the monomeric form, suggesting that conformational differences explain the differential effect of GSH depletion on STAT1 and STAT3. Overall, our findings indicate that activation of both JAK1 and STAT3 is redox-sensitive and the character of IL-6 type cytokine signaling in cardiac myocytes is sensitive to changes in the cellular redox status. In cardiac myocytes, activation of STAT1 may be favored over STAT3 under oxidizing conditions due to GSH depletion and/or augmented reactive oxygen species production, such as in ischemia-reperfusion and heart failure.


Journal of Immunology | 2014

Hydrogen sulfide [corrected] increases survival during sepsis: protective effect of CHOP inhibition.

Marcella Ferlito; Qihong Wang; William B. Fulton; Paul M. Colombani; Luigi Marchionni; Karen Fox-Talbot; Nazareno Paolocci; Charles Steenbergen

Sepsis is a major cause of mortality, and dysregulation of the immune response plays a central role in this syndrome. H2S, a recently discovered gaso-transmitter, is endogenously generated by many cell types, regulating a number of physiologic processes and pathophysiologic conditions. We report that H2S increased survival after experimental sepsis induced by cecal ligation and puncture (CLP) in mice. Exogenous H2S decreased the systemic inflammatory response, reduced apoptosis in the spleen, and accelerated bacterial eradication. We found that C/EBP homologous protein 10 (CHOP), a mediator of the endoplasmic reticulum stress response, was elevated in several organs after CLP, and its expression was inhibited by H2S treatment. Using CHOP-knockout (KO) mice, we demonstrated for the first time, to our knowledge, that genetic deletion of Chop increased survival after LPS injection or CLP. CHOP-KO mice displayed diminished splenic caspase-3 activation and apoptosis, decreased cytokine production, and augmented bacterial clearance. Furthermore, septic CHOP-KO mice treated with H2S showed no additive survival benefit compared with septic CHOP-KO mice. Finally, we showed that H2S inhibited CHOP expression in macrophages by a mechanism involving Nrf2 activation. In conclusion, our findings show a protective effect of H2S treatment afforded, at least partially, by inhibition of CHOP expression. The data reveal a major negative role for the transcription factor CHOP in overall survival during sepsis and suggest a new target for clinical intervention, as well potential strategies for treatment.


Engineering | 2015

Nitroxyl, a New Generation of Positive Inotropic Agent for Heart Failure

Ye Tian; Nazareno Paolocci; Wei Dong Gao

1 Department of Pathophysiology, Harbin Medical University, Harbin 150086, China; 2 Division of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA; 3 Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA * Correspondence author. E-mail: [email protected] ※ http://www.medscape.com/viewarticle/843901 ※※ http://www.cardioxyl.com


Journal of the American College of Cardiology | 2012

Cardioprotective Effect of Beta-3 Adrenergic Receptor Agonism Role of Neuronal Nitric Oxide Synthase

Xiaolin Niu; Vabren L. Watts; Oscar H. Cingolani; Vidhya Sivakumaran; Jordan S. Leyton-Mange; Carla L. Ellis; Karen L. Miller; Konrad Vandegaer; Djahida Bedja; Kathleen L. Gabrielson; Nazareno Paolocci; David A. Kass; Lili A. Barouch


Frontiers in Bioscience | 2010

Nitroxyl enhances myocyte Ca2+ transients by exclusively targeting SR Ca2+-cycling

Kohr Mj; Nina Kaludercic; Carlo G. Tocchetti; Dong Gao W; David A. Kass; Janssen Pm; Nazareno Paolocci; Mark T. Ziolo


Biophysical Journal | 2015

From metabolomics to fluxomics: A computational procedure to translate metabolite profiles into metabolic fluxes

Sonia Cortassa; Viviane Caceres; Lauren N. Bell; Brian O’Rourke; Nazareno Paolocci; Miguel A. Aon

Collaboration


Dive into the Nazareno Paolocci's collaboration.

Top Co-Authors

Avatar

Carlo G. Tocchetti

University of Naples Federico II

View shared research outputs
Top Co-Authors

Avatar

Djahida Bedja

Johns Hopkins University School of Medicine

View shared research outputs
Top Co-Authors

Avatar

Miguel A. Aon

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Kathleen L. Gabrielson

Johns Hopkins University School of Medicine

View shared research outputs
Top Co-Authors

Avatar

David A. Kass

Louisiana State University

View shared research outputs
Top Co-Authors

Avatar

Chaoqin Xie

Icahn School of Medicine at Mount Sinai

View shared research outputs
Top Co-Authors

Avatar

Fadi G. Akar

Icahn School of Medicine at Mount Sinai

View shared research outputs
Top Co-Authors

Avatar

Karen L. Miller

Johns Hopkins University School of Medicine

View shared research outputs
Top Co-Authors

Avatar

Konrad Vandegaer

Johns Hopkins University School of Medicine

View shared research outputs
Researchain Logo
Decentralizing Knowledge